Pembrolizumab plus weekly paclitaxel, with investigator-choice bevacizumab, achieved statistically significant PFS and OS improvements, addressing a high unmet need in platinum-resistant ovarian ...
BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart failure, yet no pharmacological therapy is approved for PAC suppression.
The 'Low Adoption' smoke screen ...
AI-enabled fraud and the coming impact of quantum computing are redefining digital-asset security, putting pressure on owners and service providers to act now.